Skip to main content

Advertisement

Log in

LINC00312 inhibits the migration and invasion of bladder cancer cells by targeting miR-197-3p

  • Original Article
  • Published:
Tumor Biology

Abstract

To investigate the influence of the long non-coding RNA LINC00312 on bladder cancer (BC) cell invasion and metastasis by targeting miR-197-3p. BC and corresponding adjacent tissues were collected. LINC00312 and miR-197-3p were measured, and their correlation was detected through quantitative real-time PCR (qRT-PCR). BC cell line T24 was transfected and grouped (five groups) according to different transfection conditions. A scratch test was applied to analyze cell migration, and a Transwell assay was used to test cell invasion ability. Western blotting was to measure matrix metalloproteinase (MMP)-2, MMP-9, and the tissue inhibitor of metalloproteinase 2 (TIMP2) protein levels. qRT-PCR indicated that LINC00312 expression was lower but miR-197-3p expression was higher in BC tissues compared with adjacent tissues; LINC00312 was negatively correlated with miR-197-3p. The migration test revealed that the downregulation of miR-197-3p and overexpression of LINC00312 inhibited cell migration and invasion abilities, while the overexpression of miR-197-3p and the upregulation of LINC00312 promoted cell migration and invasion. BC cells with downregulated miR-197-3p or upregulated LINC00312 had low MMP-2 and MMP-9 levels but high TIMP2. LINC00312 inhibited BC cell invasion and metastasis through mediating miR-197-3p.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7

Similar content being viewed by others

References

  1. Bansal N, Gupta AK, Gupta A, Sankhwar SN, Mahdi AA. Serum-based protein biomarkers of bladder cancer: a pre- and post-operative evaluation. J Pharm Biomed Anal. 2016;124:22–5. doi:10.1016/j.jpba.2016.02.026.

    Article  CAS  PubMed  Google Scholar 

  2. Wang J, Zhang X, Wang L, Dong Z, Du L, Yang Y, et al. Downregulation of urinary cell-free microRNA-214 as a diagnostic and prognostic biomarker in bladder cancer. J Surg Oncol. 2015;111(8):992–9. doi:10.1002/jso.23937.

    Article  CAS  PubMed  Google Scholar 

  3. Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012. CA Cancer J Clin. 2015;65(2):87–108. doi:10.3322/caac.21262.

    Article  PubMed  Google Scholar 

  4. Lorenzatti Hiles G, Bucheit A, Rubin JR, Hayward A, Cates AL, Day KC, et al. ADAM15 is functionally associated with the metastatic progression of human bladder cancer. PLoS One. 2016;11(3):e0150138. doi:10.1371/journal.pone.0150138.

    Article  PubMed  PubMed Central  Google Scholar 

  5. Jacobs BL, Lee CT, Montie JE. Bladder cancer in 2010: how far have we come? CA Cancer J Clin. 2010;60(4):244–72. doi:10.3322/caac.20077.

    Article  PubMed  Google Scholar 

  6. Amira AT, Mejri S, Belhaj R, Karkni W, Chebil M, Rammeh S. Prognostic value of Immunohistochemical expression profile of epidermal growth factor receptor in urothelial bladder cancer. J Immunoassay Immunochem. 2016. doi:10.1080/15321819.2016.1146757.

    Google Scholar 

  7. Griffiths TR. Action on bladder C. Current perspectives in bladder cancer management. Int J Clin Pract. 2013;67(5):435–48. doi:10.1111/ijcp.12075.

    Article  CAS  PubMed  Google Scholar 

  8. Yue B, Sun B, Liu C, Zhao S, Zhang D, Yu F, et al. Long non-coding RNA Fer-1-like protein 4 suppresses oncogenesis and exhibits prognostic value by associating with miR-106a-5p in colon cancer. Cancer Sci. 2015;106(10):1323–32. doi:10.1111/cas.12759.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Rinn JL, Chang HY. Genome regulation by long noncoding RNAs. Annu Rev Biochem. 2012;81:145–66. doi:10.1146/annurev-biochem-051410-092902.

    Article  CAS  PubMed  Google Scholar 

  10. Zhang W, Huang C, Gong Z, Zhao Y, Tang K, Li X, et al. Expression of LINC00312, a long intergenic non-coding RNA, is negatively correlated with tumor size but positively correlated with lymph node metastasis in nasopharyngeal carcinoma. J Mol Histol. 2013;44(5):545–54. doi:10.1007/s10735-013-9503-x.

    Article  CAS  PubMed  Google Scholar 

  11. Yu H, Xu Q, Liu F, Ye X, Wang J, Meng X. Identification and validation of long noncoding RNA biomarkers in human non-small-cell lung carcinomas. J Thorac Oncol. 2015;10(4):645–54. doi:10.1097/JTO.0000000000000470.

    Article  CAS  PubMed  Google Scholar 

  12. Fang YX, Chang YL, Gao WQ. MicroRNAs targeting prostate cancer stem cells. Exp Biol Med (Maywood). 2015;240(8):1071–8. doi:10.1177/1535370215584935.

    Article  CAS  Google Scholar 

  13. Ninomiya M, Kondo Y, Funayama R, Nagashima T, Kogure T, Kakazu E, et al. Distinct microRNAs expression profile in primary biliary cirrhosis and evaluation of miR 505-3p and miR197-3p as novel biomarkers. PLoS One. 2013;8(6):e66086. doi:10.1371/journal.pone.0066086.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Yang Y, Li F, Saha MN, Abdi J, Qiu L, Chang H. miR-137 and miR-197 induce apoptosis and suppress tumorigenicity by targeting MCL-1 in multiple myeloma. Clin Cancer Res. 2015;21(10):2399–411. doi:10.1158/1078-0432.CCR-14-1437.

    Article  CAS  PubMed  Google Scholar 

  15. Sand M, Bechara FG, Gambichler T, Sand D, Friedlander MR, Bromba M, et al. Next-generation sequencing of the basal cell carcinoma miRNome and a description of novel microRNA candidates under neoadjuvant vismodegib therapy: an integrative molecular and surgical case study. Ann Oncol. 2016;27(2):332–8. doi:10.1093/annonc/mdv551.

    Article  CAS  PubMed  Google Scholar 

  16. Booton R, Lindsay MA. Emerging role of MicroRNAs and long noncoding RNAs in respiratory disease. Chest. 2014;146(1):193–204. doi:10.1378/chest.13-2736.

    Article  CAS  PubMed  Google Scholar 

  17. Gutschner T, Diederichs S. The hallmarks of cancer: a long non-coding RNA point of view. RNA Biol. 2012;9(6):703–19. doi:10.4161/rna.20481.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Matullo G, Naccarati A, Pardini B. MicroRNA expression profiling in bladder cancer: the challenge of next-generation sequencing in tissues and biofluids. Int J Cancer. 2016;138(10):2334–45. doi:10.1002/ijc.29895.

    Article  CAS  PubMed  Google Scholar 

  19. van Rhijn BW, Musquera M, Liu L, Vis AN, Zuiverloon TC, van Leenders GJ, et al. Molecular and clinical support for a four-tiered grading system for bladder cancer based on the WHO 1973 and 2004 classifications. Mod Pathol. 2015;28(5):695–705. doi:10.1038/modpathol.2014.154.

    Article  PubMed  Google Scholar 

  20. Sano T, Coit DG, Kim HH, Roviello F, Kassab P, Wittekind C, et al. Proposal of a new stage grouping of gastric cancer for TNM classification: international gastric cancer association staging project. Gastric Cancer. 2016. doi:10.1007/s10120-016-0601-9.

    Google Scholar 

  21. Roderburg C, Luedde T. Circulating microRNAs as markers of liver inflammation, fibrosis and cancer. J Hepatol. 2014;61(6):1434–7. doi:10.1016/j.jhep.2014.07.017.

    Article  PubMed  Google Scholar 

  22. Song MK, Choi HS, Lee HS, Kim YJ, Park YK, Ryu JC. Analysis of microRNA and mRNA expression profiles highlights alterations in modulation of the MAPK pathway under octanal exposure. Environ Toxicol Pharmacol. 2014;37(1):84–94. doi:10.1016/j.etap.2013.11.005.

    Article  CAS  PubMed  Google Scholar 

  23. Ebert MS, Sharp PA. Emerging roles for natural microRNA sponges. Curr Biol. 2010;20(19):R858–61. doi:10.1016/j.cub.2010.08.052.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. Wang KC, Yang YW, Liu B, Sanyal A, Corces-Zimmerman R, Chen Y, et al. A long noncoding RNA maintains active chromatin to coordinate homeotic gene expression. Nature. 2011;472(7341):120–4. doi:10.1038/nature09819.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. Cesana M, Cacchiarelli D, Legnini I, Santini T, Sthandier O, Chinappi M, et al. A long noncoding RNA controls muscle differentiation by functioning as a competing endogenous RNA. Cell. 2011;147(2):358–69. doi:10.1016/j.cell.2011.09.028.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  26. Shi Y, Wang Y, Luan W, Wang P, Tao T, Zhang J, et al. Long non-coding RNA H19 promotes glioma cell invasion by deriving miR-675. PLoS One. 2014;9(1):e86295. doi:10.1371/journal.pone.0086295.

    Article  PubMed  PubMed Central  Google Scholar 

  27. Yoon JH, Abdelmohsen K, Gorospe M. Functional interactions among microRNAs and long noncoding RNAs. Semin Cell Dev Biol. 2014;34:9–14. doi:10.1016/j.semcdb.2014.05.015.

    Article  CAS  PubMed  Google Scholar 

  28. Song H, Sun W, Ye G, Ding X, Liu Z, Zhang S, et al. Long non-coding RNA expression profile in human gastric cancer and its clinical significances. J Transl Med. 2013;11(225). doi:10.1186/1479-5876-11-225.

  29. Nie Y, Liu X, Qu S, Song E, Zou H, Gong C. Long non-coding RNA HOTAIR is an independent prognostic marker for nasopharyngeal carcinoma progression and survival. Cancer Sci. 2013;104(4):458–64. doi:10.1111/cas.12092.

    Article  CAS  PubMed  Google Scholar 

  30. Zhang JG, Wang JJ, Zhao F, Liu Q, Jiang K, Yang GH. MicroRNA-21 (miR-21) represses tumor suppressor PTEN and promotes growth and invasion in non-small cell lung cancer (NSCLC. Clin Chim Acta. 2010;411(11–12):846–52. doi:10.1016/j.cca.2010.02.074.

    Article  CAS  PubMed  Google Scholar 

  31. Saito M, Schetter AJ, Mollerup S, Kohno T, Skaug V, Bowman ED, et al. The association of microRNA expression with prognosis and progression in early-stage, non-small cell lung adenocarcinoma: a retrospective analysis of three cohorts. Clin Cancer Res. 2011;17(7):1875–82. doi:10.1158/1078-0432.CCR-10-2961.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  32. Wang KC, Chang HY. Molecular mechanisms of long noncoding RNAs. Mol Cell. 2011;43(6):904–14. doi:10.1016/j.molcel.2011.08.018.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  33. Ma L, Reinhardt F, Pan E, Soutschek J, Bhat B, Marcusson EG, et al. Therapeutic silencing of miR-10b inhibits metastasis in a mouse mammary tumor model. Nat Biotechnol. 2010;28(4):341–7. doi:10.1038/nbt.1618.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  34. Giza DE, Vasilescu C, Calin GA. Key principles of miRNA involvement in human diseases. Discoveries (Craiova). 2014;2(4):e34. doi:10.15190/d.2014.26.

    Article  Google Scholar 

  35. Fan M, Li X, Jiang W, Huang Y, Li J, Wang ZA. Long non-coding RNA, PTCSC3, as a tumor suppressor and a target of miRNAs in thyroid cancer cells. Exp Ther Med. 2013;5(4):1143–6. doi:10.3892/etm.2013.933.

    PubMed  PubMed Central  Google Scholar 

  36. Tang L, Zhang W, Su B, Long YB. Noncoding RNA HOTAIR is associated with motility, invasion, and metastatic potential of metastatic melanoma. Biomed Res Int. 2013. doi:10.1155/2013/251098.

    Google Scholar 

  37. Sun M, Liu XH, Wang KM, Nie FQ, Kong R, Yang JS, et al. Downregulation of BRAF activated non-coding RNA is associated with poor prognosis for non-small cell lung cancer and promotes metastasis by affecting epithelial-mesenchymal transition. Mol Cancer. 2014;13(68). doi:10.1186/1476-4598-13-68.

  38. TY W, Zhang TH, LM Q, Feng JP, Tian LL, Zhang BH, et al. MiR-19a is correlated with prognosis and apoptosis of laryngeal squamous cell carcinoma by regulating TIMP-2 expression. Int J Clin Exp Pathol. 2014;7(1):56–63.

    Google Scholar 

  39. Yan A, Yang C, Chen Z, Li C, Cai L. MiR-761 promotes progression and metastasis of non-small cell lung cancer by targeting ING4 and TIMP2. Cell Physiol Biochem. 2015;37(1):55–66. doi:10.1159/000430333.

    Article  CAS  PubMed  Google Scholar 

  40. Filkova M, Aradi B, Senolt L, Ospelt C, Vettori S, Mann H, et al. Association of circulating miR-223 and miR-16 with disease activity in patients with early rheumatoid arthritis. Ann Rheum Dis. 2014;73(10):1898–904. doi:10.1136/annrheumdis-2012-202815.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

This study was supported by the Jiangsu Planned Projects for Postdoctoral Research Fund (1501142B). We would like to give our sincere appreciation to the reviewers for their helpful comments on this article.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Jun-Song Meng.

Ethics declarations

Conflicts of interest

None

Additional information

Yun-Yan Wang, Zi-Yu Wu, and Gong-Cheng Wang are regarded as co-first authors.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Wang, YY., Wu, ZY., Wang, GC. et al. LINC00312 inhibits the migration and invasion of bladder cancer cells by targeting miR-197-3p. Tumor Biol. 37, 14553–14563 (2016). https://doi.org/10.1007/s13277-016-5303-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13277-016-5303-8

Keywords

Navigation